Author Archives: Forest Ray PhD

Hydrogel Device Hints at Better Option for Brain Stimulation

A flexible hydrogel-based device, implanted in the brains of mice, allowed scientists to stimulate and detect brain signals — in deep brain regions — in real time, a study reported. The hydrogel device functions for nearly six months, and triggers less of a reaction and lesser scarring than current electrodes,…

California Earmarks $8.4M for Parkinson’s Disease Registry

California has committed $8.4 million to the California Parkinson’s Disease Registry (CPDR) and efforts to expand it to other neurodegenerative diseases over the next four years. The Michael J. Fox Foundation for Parkinson’s Research (MJFF) commended Gov. Gavin Newsom for signing the state’s fiscal year 2021–2022 budget,…

New Method to Improve Brain Stimulation Treatments

Stimulating brain regions to treat Parkinson’s disease, depression, and other disorders involving brain damage could become more precise, thanks to a new way of mapping the brain circuitry involved in those conditions. The study describing this research, “Brain stimulation and brain lesions converge on common causal…

Probiotics May Reduce Some Signs of Gut Inflammation

Probiotic supplements could prove a useful add-on therapy for people with Parkinson’s disease, a recent study suggests. The study, “Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson’s disease,” was published in the International Journal…

Alector, GSK Partner to Develop 2 Therapies for Dementia

Alector and GlaxoSmithKline (GSK) will collaborate in developing and commercializing two therapies aimed at treating an uncommon type of dementia that can cause problems with behavior and language. Both investigational therapies — AL001 and AL101 — can be used across a range of neurodegenerative disorders, including Parkinson’s,…

MJFF Funds 36 Studies Totaling $6.3M

The Michael J. Fox Foundation (MJFF) is funding a variety of Parkinson’s disease studies, ranging from projects focused on environmental risk factors and exercise to therapeutic gene targets and new tests. A total of 36 grants were awarded, amounting to $6.3 million. Several of the MJFF-funded projects are…

Using Meth Increases Risk of Developing Parkinson’s

Methamphetamine users are more likely to experience premature stroke, Parkinson’s disease, and parkinsonism, according to results of a recent study. The study, “Methamphetamine and heightened risk for early-onset stroke and Parkinson’s disease: A review,” was published in the journal Experimental Neurology. Increasing methamphetamine use is a…

Senses Related to Smell May Be Predictor of Parkinson’s

A chemical sense related to smell, called the trigeminal system, may help researchers understand which people who lose their sense of smell will later develop Parkinson’s disease. Parkinson Canada is supporting this research through a $45,000, yearlong grant, given to Johannes Frasnelli, PhD, of l’Université de Québec á…

Algorithm May Make Deep Brain Stimulation More Adaptive Process

An algorithm that detects and removes electrical interference produced by deep brain stimulation (DBS) devices could make it possible to design adaptable devices that better treat the tremors related to Parkinson’s disease, researchers report. Their algorithm is described in the study “Uncovering biomarkers during therapeutic neuromodulation…

MJFF Funding 4 Studies Into Environmental Toxins and Parkinson’s

Funding from the Michael J. Fox Foundation (MJFF) will support four projects investigating possible connections between toxic environmental factors and Parkinson’s disease, including those encountered in military service and daily life exposure to pesticides and air pollution. Although Parkinson’s is a complex disorder and unlikely to have a single…